Mechanisms involved in anti-aging effects of guarana (Paullinia cupana) in Caenorhabditis elegans

Abstract

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.

Aging; Antioxidant; Guarana; Lifespan; Natural products; Xanthines

Introduction

Paullinia cupana, also referred to as guarana, is a native plant to the Amazon basin and especially common in Brazil. The powder of its seeds is habitually ingested by people of all ages in the Amazon region mainly for its tonic and stimulant properties (¹). Moreover, guarana is a key ingredient in various energy drinks consumed in many countries (²). Other reported pharmacological effects of guarana include weight loss, lowering platelet thromboxane synthesis, protecting against gastric lesions, antioxidant activity, and anti-inflammatory effects [for review see: (¹)]. However, when consumed in excess, guarana may also adversely affect human health, causing anxiety, sleep disruption, and tachycardia, for example, due to its high content of caffeine (²,³).

Extension in longevity in people living in Maués, an Amazon region in Brazil, has been associated to Amazonian diet, including habitual intake of guarana (⁴). Furthermore, an epidemiological study associated guarana ingestion with low prevalence of chronic age-related diseases in the Amazonian population (⁵). Recently, a study also demonstrated anti-aging potential of guarana seed extract in Caenorhabditis elegans (⁶). However, the mechanisms underlying the guarana effects on aging were not identified.

C. elegans has been a suitable model for understanding organismal responses to various synthetic and natural compounds and their influence on aging and lifespan. Vital biological pathways and numerous aspects of aging are analogous in nematodes and mammals, including humans (⁷).

Since the percentage of older people is growing worldwide accompanied with increased frequency of age-related disease, it is essential to identify efficacious therapies and therapeutic targets that might improve the quality of life (⁸). Herein, we investigated the putative pathways that regulate the effects of guarana on lifespan using C. elegans.

Material and Methods

Chemicals

Agar, ethanol (96%), chloroform, cholesterol, FUDR (5-fluoro-2′-deoxyuridine), protease inhibitor, phosphatase inhibitor cocktails, polymerase chain reaction (PCR) primers, and bovine serum albumin (BSA) were purchased from Sigma (USA). TaqMan¯ primers used for qRT-PCR analysis and Trizol were purchased from Applied Biosystems/Thermo Fisher Scientific Corporation (USA). All other reagents were purchased from Synth (Brazil).

Strains and maintenance

Strains used in this study were Bristol N2 (wild-type); CB1370, daf-2 (e1370) III; CF1038, daf-16 (mu86) I; EU1, skn-1(zu67); PS3551, hsf-1(sy441) I; TK22, mev-1(kn1); and VC199, sir-2.1(ok434), obtained from the Caenorhabditis Genetics Center (CGC), University of Minnesota, USA, as well as the Escherichia coli OP50. EG6890 strain, ador-1 (ox489), was kindly supplied from Dr. Erik Jorgensen laboratory (University of Utah, USA). This strain has a deletion from 1 kb upstream and the first three exons of the ador-1 gene, and was outcrossed 6 times; ador-1 gene encodes an ortholog of human adenosine receptor (⁹).

Nematodes were maintained and assayed at 20°C on nematode growth medium (NGM) agar plates carrying a lawn of E. coli OP50 (¹⁰). Synchronization of nematode cultures was achieved by bleaching treatment of gravid hermaphrodites and eggs were allowed to hatch overnight in M9 buffer (42 mM Na₂HPO₄, 22 mM KH₂PO₄, 8.5 mM NaCl, and 1 mM MgSO₄) (¹⁰).

Plant material and extract preparation

The powder of toasted seeds of Paullinia cupana Kunth var. sorbilis (Mart.), the guarana, was isolated and supplied by EMBRAPA Oriental (Agropecuary Research Brazilian Enterprise) located in Western Amazon in Maués, Amazonas, Brazil. The hydro-alcoholic extract was obtained as described elsewhere (¹¹). Briefly, the extract was produced using 70% ethanol. After 24 h, the resulting solution was filtered, the ethanol was removed, and the extract was lyophilized. The predominant xanthines and catechins presented in the guarana extract were analyzed by means of HPLC, showing the following concentrations: caffeine=12.240 mg/g, theobromine=6.733 mg/g and total catechins=4.336 mg/g (¹¹).

Treatment of the worms

NGM plates carrying a lawn of E. coli OP50 (as food source) were previously incubated at 37°C overnight. Lyophilized guarana ethanolic extract (GEE) was dissolved in cold distilled autoclaved water (121°C, 30 min) and spread over the plates at final concentrations of 100, 500 and 1,000 µg/mL of agar. Synchronized L1 larvae (¹⁰) were transferred with a pipette to the surface of treatment plates and cultured to adulthood at 20°C.

Lifespan

Lifespan analyses started at L4 larvae in NGM plates seeded with E. coli OP50 in the absence or presence of GEE (day 0). Animals were transferred to fresh plates with or without GEE every other day to avoid confounding of generations, and scored at the same time until death. Absence of response to a mechanical stimulus was scored as death. Worms were censored if they crawled off the plate, displayed extruded internal organs, or died because of hatching progeny inside the uterus. Lifespan assays were repeated three times with 60–120 worms per assay. Through mutant strains, the major known longevity pathways were analyzed (¹²,¹³): i) daf-2 and daf-16, the insulin/insulin-like growth factor (IGF)-1 signaling (IIS), which the DAF-2 receptor signals through a conserved PI3-kinase/AKT pathway and down regulates DAF-16/FOXO, responsible for promoting expression of genes that confer extended longevity and enhanced stress resistance; ii) skn-1, which is related to vertebrate Nrf family proteins and promotes expression of detoxification enzymes in response to oxidative stress, like glutathione-S-transferase; iii) sir-2.1, which encodes a histone deacetylase-like protein that integrates metabolic status with lifespan, and is associated to caloric restriction; and iv) hsf-1, which encodes heat-shock transcription factor-1 (HSF-1) and induces activation of various heat-shock genes or chaperones involved in maintaining the conformational homeostasis of proteins among other important functions. A possible relationship between longevity and purinergic signaling was also investigated through ador-1 mutant strain.

As bacteria play a role in C. elegans mortality, E.coli OP50 growth was evaluated in the presence or absence of GEE to investigate if beneficial effects could be a response to an antimicrobial property. The absorbance of the bacteria was measured during a 12-h period in liquid medium (¹⁴).

Health span

Behavior parameters related to health span were evaluated (¹⁵). Pharyngeal pumping was assessed with a Nikon E200 microscope by observing the number of pharyngeal contractions during a 60-s interval in wild-type young adults.

Thrash frequency was selected for analysis of locomotion. Wild-type young adults from control or GEE treatments were individually picked and placed in a drop of M9. The worms were allowed to adapt for 1 min and then the number of thrashes were quantified with a Nikon E200 microscope during a 20-s interval. A thrash was defined as a change in the direction of bending at the middle of the body.

Analyses were carried out in three independent assays. Thirty nematodes were examined per group.

RNA isolation and real-time polymerase chain reaction (RT-qPCR)

Wild-type worms in 9-day-old adult worms were analyzed for gene expression related to longevity and oxidative stress responses. After adulthood, worms were transferred every other day to plates containing 150 mM of FUDR (5-fluoro-2′-deoxyuridine) to inhibit reproduction, in the presence or absence of GEE. RNA from 20,000 worms per condition was isolated using Trizol followed by chloroform extraction, as previously described (¹⁶) and 1 μg of input RNA was reverse transcribed to cDNA by Applied Biosystems high capacity cDNA reverse transcription kit (Applied Biosystems, USA). Expression analysis was performed by Custom TaqMan¯ Array analysis utilizing the corresponding TaqMan¯ Gene Expression assays for mitochondrial superoxide dismutase sod-3 (Ce02404515_g1), glutathione-S-transferase gst-4 (Ce02458730_g1), gamma glutamylcysteine synthetase gcs-1 (Ce02436726_g1), daf-16 (Ce02422835_g1), sir-2.1 (Ce02459018_g1), hsf-1 (Ce02423758_m1), heat shock protein hsp-16.2 (Ce02506738_s1), and skn-1 (Ce02407445_g1) (Applied Biosystems). Target gene expression was normalized to the expression values of actin afd-1 (Ce02414573_m1). The relative expression of each gene was determined by the 2^−ΔΔCt method (¹⁷) and data are reported as fold change in mRNA levels relative to afd-1. This experiment was carried out in three independent worm preparations, each in triplicate.

Statistical analysis

Statistical analyses were performed using GraphPad Prism version 5 for Windows (GraphPad Software, USA). The results are reported as means±SD of at least three individual experiments. Student's t-test was used to compare pairs of groups, whereas a one or two-way ANOVA followed by Bonferroni's post hoc test was used to compare three or more groups. All survival curves were analyzed by the log-rank (Mantel-Cox) test. Statistical significance was determined as P<0.05.

Results

In our study, control wild-type C. elegans had a mean lifespan of 11 days and maximum lifespan of 14 days. In media containing GEE, mean lifespan of wild-type worms was extended to 13 days at 100 µg/mL (18%) and to 15 days at 500 and 1,000 µg/mL (36%). Maximum lifespan was extended by an average of 28% at the three tested concentrations (Table 1). There was no difference in E. coli growth in the presence or absence of 1,000 µg/mL of GEE (data not shown).

Table 1.
Lifespan of untreated and guarana ethanolic extract (GEE)-treated C. elegans.

Genotype	GEE (µg/mL)	Mean lifespan ± SD (days)	Maximum lifespan ± SD (days)
Bristol N2	0	11±1.73	14±1.81
	100	13±2.00*	17±1.91*
	500	15±1.15*	18±1.07*
	1,000	15±1.63*	18±1.33*
mev-1	0	9±1.02	12±1.22
	1,000	13±1.07*	15±1.55*
daf-2	0	23±1.70	31±1.37
	1,000	29±1.64*	36±1.38*
daf-16	0	11±1.53	13±1.28
	1,000	11±1.57	12±1.44
skn-1	0	9±1.21	11±1.23
	1,000	9±1.35	11±1.38
hsf-1	0	11±0.2	13±0.7
	1,000	11±0.6	13±0.7
sir-2.1	0	12±1.80	16±1.42
	1,000	14±2.10*	17±1.66
ador-1	0	13±1.74	17±1.62
	1,000	12±1.68	16±1.33

• Lifespan assays were performed at 20°C. Maximum lifespan is represented as the mean lifespan of the longest living 10% of the worm population. Each experiment was repeated three times starting with at least 60 nematodes per group. Data are reported as mean±SD. *P<0.05 compared to the untreated group (Mantel-Cox log-rank test).

The health span of the worms was also prolonged after GEE treatment. The extract delayed the age-related decline in pharyngeal pumping (100, 500, and 1,000 µg/mL) and thrashes (1,000 µg/mL) starting on the 9^th day of adulthood (Figure 1 A and B). Accordingly, the concentration of 1,000 µg/mL of GEE and samples of 9-day adult worms were selected for further analysis.

Figure 1.
Guarana ethanolic extract (GEE) effects on behavioral parameters related to health span. Pharyngeal pumping rate (A) and thrash frequency (B) during aging in wild-type worms. Data are reported as mean±SD (n=30 worms per group). *P<0.05 compared to control (one-way ANOVA followed by Bonferroni multiple comparison test.

GEE extract (1,000 µg/mL) extended mean lifespan of mev-1 mutants by 44% and maximum lifespan by 77.8% (Table 1), showing a connection between antioxidant and anti-aging activities. The extract also extended mean lifespan of daf-2, and sir 2.1 mutants, establishing that the extract did not act through these pathways to promote lifespan extension. In contrast, the treatment did not prolong lifespan of daf-16, skn-1, hsf-1, and ador-1 mutants (Table 1).

PCR analyses assessed gene modulation by GEE (Table 2). GEE at 1,000 µg/mL down regulated skn-1, daf-16, sir-2.1, and hsp-16.2 in 9-day-old adults. No effect was observed on hsf-1, gst-4, gcs-1, and sod-3 expression.

Table 2.
Fold change mRNA expression of genes related to longevity and oxidative stress in wild-type 9-day-old adult worms treated with guarana ethanolic extract (GEE)

Gene	0 µg/mL GEE	1,000 µg/mL GEE
skn-1	−0.017±0.037	−0.613±0.133*
daf-16	−0.026±0.087	−0.692±0.133*
sir-2.1	+0.015±0.072	−0.708±0.164*
hsf-1	+0.001±0.104	−0.154±0.150
gst-4	+0.005±0.114	−0.083±0.125
gcs-1	+0.006±0.116	−0.059±0.193
sod-3	+0.005±0.117	−0.388±0.137
hsp-16.2	−0.010±0.089	−0.670±0.228*

• This experiment was assessed by RT-qPCR and carried out in three independent worm preparations, each in triplicate. Data are reported as means of fold change in mRNA levels relative to afd-1 (actin) ±SD. *P<0.05 compared to untreated (two-way ANOVA followed by Bonferroni's multiple comparison test).

Discussion

As previously demonstrated (¹), in our study, guarana extract also extended lifespan and health span of wild-type C. elegans. Thus, putative pathways that might be implicated in its anti-aging effects were investigated. Herein, anti-aging effects were shown at a higher concentration of the extract (1,000 vs 300 µg/mL as previously demonstrated). This discrepancy may be due to differences in extract preparation (hydro-alcoholic vs aqueous extract) and delivery method (agar vs liquid medium) and may be a result of natural drifting in genetic variation in the worms' population (¹⁸,¹⁹).

Oxidative stress appears to be a major factor limiting lifespan in both C. elegans and humans and is associated to many age-related diseases (²⁰,²¹), which directs attention toward antioxidant compounds with effects in vivo. To further investigate whether GEE could extend lifespan through an antioxidant activity, its effect on mev-1 worms was evaluated. This strain is characterized by superoxide overproduction and has a shorter lifespan compared to wild-type strain (²²). Consistent with previously described antioxidant effects of guarana extract (⁶), GEE treatment significantly extended mean and maximum lifespan of mev-1 worms.

Besides that, DAF-16, HSF-1, and SKN-1 pathways, involved in the insulin/IGF signaling (IIS), appeared essential for GEE-mediated lifespan extension. Reduced IIS is associated with longevity and adaptation to adverse environmental conditions in C. elegans, Drosophila, mammals, and possibly humans (¹³). HSF-1 functions in cooperation with DAF-16 to activate the expression of common target genes, including the family of sHsp (small heat shock proteins genes) (²³). SKN-1/Nrf integrates IIS and regulates response to oxidative stress and expression of detoxification genes (²⁴).

DAF-16, HSF-1, and SKN-1 might also mediate health span extension and protein homeostasis (²⁵). DAF-16 is involved in the formation of less toxic high-molecular weight protein aggregates (²⁶), and although HSF-1 regulates protein disaggregation activity releasing small toxic aggregates, it might have a beneficial effect contributing to protein clearance through enzymatic metabolism (²⁷,²⁸). SKN-1 is best known as a regulator of antioxidant and xenobiotic defense, but it has also been implicated in additional functions that include proteostasis and metabolic regulation (²⁴).

Methylxanthines, as caffeine, are the main components of guarana and it is well known that these compounds can act through adenosine receptors in mammals (²⁹). Caffeine has been associated with beneficial effects, including aging-related effects (³⁰,³¹) and improvement of cognitive impairment phenotypes by antagonizing the adenosine receptors A₁ and A_2A in rodents (³²). Thus, we tested if the GEE-induced extension of lifespan might also depend upon ADOR-1, an adenosine receptor homolog (³³). Our results indicated that ador-1(ox489) worms failed to show extended lifespan, demonstrating, for the first time, a possible role of the purinergic system in lifespan extension. Accordingly, purinergic signaling may be profitably studied in the future as a potential target for longevity modulation.

Although GEE has high levels of caffeine, and previous studies described caffeine's effects in worms (³⁴ –³⁶), the anti-aging effects of GEE might be related to synergic effects of different compounds. The concentration of caffeine in the extract is much lower than the effective concentration previously demonstrated and it was shown that alkaloid extract from guarana did not have the same beneficial effects (⁶). Besides, data from the literature shows that extracts could have greater pharmacological activities than isolated compounds (³⁷,³⁸).

Downregulation of skn-1, daf-16, sir-2.1, and hsp-16.2 in 9-day-old C. elegans treated with GEE might reflect less need to activate these genes to repair cell damage during aging compared to untreated worms, possible due to direct antioxidant effects exerted by the extract (³⁹,⁴⁰).

Thus, this study showed that anti-aging effects of guarana are mediated by antioxidant activity and DAF-16, HSF-1, and SKN-1 pathways. In addition, ADOR-1 was also necessary for GEE effects on lifespan, indicating a possible involvement of the purinergic system in longevity. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and suggest purinergic signaling as a plausible therapeutic target for longevity studies.

Acknowledgements

The authors are thankful to the Caenorhabditis Genetics Center (CGC) at the University of Minnesota, USA for providing worm strains and to Dr. Erik Jorgensen’s laboratory (University of Utah, USA) for kindly supplying the EG6890 strain. This study was supported by Conselho Nacional de Desenvolvimento Científico e Tecnológico, Brazil (CNPq), Coordenação de Aperfeiçoamento de Pessoal a Nível Superior, Brazil (CAPES), PRONEM/FAPERGS/CNPq and MCTI/CNPq #472669/2011-7 and #475896/2012-2. Michael Aschner was supported in part by NIH grant R01 ES10563. The funding sources were not involved in study design or interpretation of data.

References

• ¹ Schimpl FC, da Silva JF, Goncalves JF, Mazzafera P. Guarana: revisiting a highly caffeinated plant from the Amazon. J Ethnopharmacol 2013; 150: 14–31, doi: 10.1016/j.jep.2013.08.023.
  » https://doi.org/10.1016/j.jep.2013.08.023
• ² Smith N, Atroch AL. Guarana's journey from regional tonic to aphrodisiac and global energy drink. Evid Based Complement Alternat Med 2010; 7: 279–282, doi: 10.1093/ecam/nem162.
  » https://doi.org/10.1093/ecam/nem162
• ³ Wikoff D, Welsh BT, Henderson R, Brorby GP, Britt J, Myers E, et al. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol 2017; 109 (Pt 1): 585–648, doi: 10.1016/j.fct.2017.04.002.
  » https://doi.org/10.1016/j.fct.2017.04.002
• ⁴ Ribeiro EE, da Cruz IBM. Dieta Amazônica. Manaus: Editora Cultural da Amazônia; 2012.
• ⁵ Krewer CC, Ribeiro EE, Ribeiro EA, Moresco RN, da Rocha MI, Montagner GF, et al. Habitual intake of guarana and metabolic morbidities: an epidemiological study of an elderly amazonian population. Phytother Res 2011; 25: 1367–1374, doi: 10.1002/ptr.3437.
  » https://doi.org/10.1002/ptr.3437
• ⁶ Peixoto H, Roxo M, Rohrig T, Richling E, Wang X, Wink M. Anti-aging and antioxidant potential of Paullinia cupana var. sorbilis: Findings in Caenorhabditis elegans indicate a new utilization for roasted seeds of guarana. Medicines (Basel) 2017; 4: 61, doi: 10.3390/medicines4030061.
  » https://doi.org/10.3390/medicines4030061
• ⁷ Olsen A. Ageing: lessons from C. elegans New York Springer Berlin Heidelberg; 2016
• ⁸ WHO (World Health Organization). Global Health and Aging. NIH Publication n. 11-7737; 2011. http://www.who.int/ageing/publications/global_health.pdf
  » http://www.who.int/ageing/publications/global_health.pdf
• ⁹ Wormbase. https://wormbase.org/species/c_elegans/gene/WBGene00011878#0-9g-3 Accessed January 21, 2017
  » https://wormbase.org/species/c_elegans/gene/WBGene00011878#0-9g-3
• ¹⁰ Brenner S. The genetics of Caenorhabditis elegans Genetics 1974; 77: 71–94.
• ¹¹ Bittencourt LS, Machado DC, Machado MM, dos Santos GF, Algarve TD, Marinowic DR, et al. The protective effects of guarana extract (Paullinia cupana) on fibroblast NIH-3T3 cells exposed to sodium nitroprusside. Food Chem Toxicol 2013; 53: 119–125, doi: 10.1016/j.fct.2012.11.041.
  » https://doi.org/10.1016/j.fct.2012.11.041
• ¹² Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000; 408: 255–262, doi: 10.1038/35041700.
  » https://doi.org/10.1038/35041700
• ¹³ Kuningas M, Mooijaart SP, van Heemst D, Zwaan BJ, Slagboom PE, Westendorp RG. Genes encoding longevity: from model organisms to humans. Aging Cell 2008; 7: 270–280, doi: 10.1111/j.1474-9726.2008.00366.x.
  » https://doi.org/10.1111/j.1474-9726.2008.00366.x
• ¹⁴ Bonomo Lde F, Silva DN, Boasquivis PF, Paiva FA, Guerra JF, Martins TA, et al. Acai (Euterpe oleracea Mart.) modulates oxidative stress resistance in Caenorhabditis elegans by direct and indirect mechanisms. PLoS One 2014; 9: e89933, doi: 10.1371/journal.pone.0089933.
  » https://doi.org/10.1371/journal.pone.0089933
• ¹⁵ Bansal A, Zhu LJ, Yen K, Tissenbaum HA. Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants. Proc Natl Acad Sci USA 2015; 112: E277-E286, doi: 10.1073/pnas.1412192112.
  » https://doi.org/10.1073/pnas.1412192112
• ¹⁶ Chomczynski P, Mackey K. Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 1995; 19: 942–945.
• ¹⁷ Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402–408, doi: 10.1006/meth.2001.1262.
  » https://doi.org/10.1006/meth.2001.1262
• ¹⁸ Barriere A, Felix MA. WormBook: Natural variation and population genetics of Caenorhabditis elegans 2005; p1-p19, doi: 10.1895/wormbook.1.43.1.
  » https://doi.org/10.1895/wormbook.1.43.1
• ¹⁹ Zheng SQ, Ding AJ, Li GP, Wu GS, Luo HR. Drug absorption efficiency in Caenorhbditis elegans delivered by different methods. PLoS One 2013; 8: e56877, doi: 10.1371/journal.pone.0056877.
  » https://doi.org/10.1371/journal.pone.0056877
• ²⁰ Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006; 97:1634–1658, doi: 10.1111/j.1471-4159.2006.03907.x.
  » https://doi.org/10.1111/j.1471-4159.2006.03907.x
• ²¹ Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis 2015; 6: 109–120, doi: 10.14336/AD.2014.0305.
  » https://doi.org/10.14336/AD.2014.0305
• ²² Ishii N, Fujii M, Hartman PS, Tsuda M, Yasuda K, Senoo-Matsuda N, et al. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 1998; 394: 694–697, doi: 10.1038/29331.
  » https://doi.org/10.1038/29331
• ²³ Hsu AL, Murphy CT, Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003; 300: 1142–1145, doi: 10.1126/science.1083701.
  » https://doi.org/10.1126/science.1083701
• ²⁴ Blackwell TK, Steinbaugh MJ, Hourihan JM, Ewald CY, Isik M. SKN-1/Nrf, stress responses, and aging in Caenorhabditis elegans Free Radic Biol Med 2015; 88 (Pt B): 290–301, doi: 10.1016/j.freeradbiomed.2015.06.008.
  » https://doi.org/10.1016/j.freeradbiomed.2015.06.008
• ²⁵ Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A. Opposing activities protect against age-onset proteotoxicity. Science 2006; 313: 1604–1610, doi: 10.1126/science.1124646.
  » https://doi.org/10.1126/science.1124646
• ²⁶ Ushikubo H, Tanimoto Y, Abe K, Asakawa T, Kan T, Akaishi T. 3,3′,4′,5′-Tetrahydroxyflavone induces formation of large aggregates of amyloid beta protein. Biol Pharm Bull 2014; 37: 748–754, doi: 10.1248/bpb.b13-00709.
  » https://doi.org/10.1248/bpb.b13-00709
• ²⁷ Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, et al. Metabolic regulation of brain Abeta by neprilysin. Science 2001; 292: 1550–1552, doi: 10.1126/science.1059946.
  » https://doi.org/10.1126/science.1059946
• ²⁸ Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X, et al. Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 2003; 40: 1087–1093. doi: 10.1016/S0896-6273(03)00787-6.
  » https://doi.org/10.1016/S0896-6273(03)00787-6
• ²⁹ Chen JF, Eltzschig HK, Fredholm BB. Adenosine receptors as drug targets--what are the challenges? Nat Rev Drug Discov 2013; 12: 265–286, doi: 10.1038/nrd3955.
  » https://doi.org/10.1038/nrd3955
• ³⁰ Laurent C, Eddarkaoui S, Derisbourg M, Leboucher A, Demeyer D, Carrier S, et al. Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology. Neurobiol Aging 2014; 35: 2079–2090, doi: 10.1016/j.neurobiolaging.2014.03.027.
  » https://doi.org/10.1016/j.neurobiolaging.2014.03.027
• ³¹ Rivera-Oliver M, Diaz-Rios M. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. Life Sci 2014; 101: 1–9, doi: 10.1016/j.lfs.2014.01.083.
  » https://doi.org/10.1016/j.lfs.2014.01.083
• ³² Cunha RA, Agostinho PM. Chronic caffeine consumption prevents memory disturbance in different animal models of memory decline. J Alzheimers Dis 2010; 20 (Suppl 1): S95-S116, doi: 10.3233/JAD-2010-1408.
  » https://doi.org/10.3233/JAD-2010-1408
• ³³ Shaye DD, Greenwald I. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS One 2011; 6: e20085, doi: 10.1371/journal.pone.0020085.
  » https://doi.org/10.1371/journal.pone.0020085
• ³⁴ Sutphin GL, Bishop E, Yanos ME, Moller RM, Kaeberlein M. Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans Longev Healthspan 2012; 1: 9, doi: 10.1186/2046-2395-1-9.
  » https://doi.org/10.1186/2046-2395-1-9
• ³⁵ Lublin A, Isoda F, Patel H, Yen K, Nguyen L, Hajje D, et al. FDA-approved drugs that protect mammalian neurons from glucose toxicity slow aging dependent on cbp and protect against proteotoxicity. PLoS One 2011; 6: e27762, doi: 10.1371/journal.pone.0027762.
  » https://doi.org/10.1371/journal.pone.0027762
• ³⁶ Bridi JC, Barros AG, Sampaio LR, Ferreira JC, Antunes Soares FA, Romano-Silva MA. Lifespan extension induced by caffeine in Caenorhabditis elegans is partially dependent on adenosine signaling. Front Aging Neurosci 2015; 7: 220, doi: 10.3389/fnagi.2015.00220.
  » https://doi.org/10.3389/fnagi.2015.00220
• ³⁷ Adebajo AC, Iwalewa EO, Obuotor EM, Ibikunle GF, Omisore NO, Adewunmi CO, et al. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J Ethnopharmacol 2009; 122: 10–19, doi: 10.1016/j.jep.2008.11.015.
  » https://doi.org/10.1016/j.jep.2008.11.015
• ³⁸ Pietrovski EF, Rosa KA, Facundo VA, Rios K, Marques MC, Santos AR. Antinociceptive properties of the ethanolic extract and of the triterpene 3beta,6beta,16beta-trihidroxilup-20(29)-ene obtained from the flowers of Combretum leprosum in mice. Pharmacol Biochem Behav 2006; 83: 90–99, doi: 10.1016/j.pbb.2005.12.010.
  » https://doi.org/10.1016/j.pbb.2005.12.010
• ³⁹ Mattei R, Dias RF, Espinola EB, Carlini EA, Barros SB. Guarana (Paullinia cupana): toxic behavioral effects in laboratory animals and antioxidants activity in vitro. J Ethnopharmacol 1998; 60: 111–116, doi: 10.1016/S0378-8741(97)00141-4.
  » https://doi.org/10.1016/S0378-8741(97)00141-4
• ⁴⁰ Portella Rde L, Barcelos RP, da Rosa EJ, Ribeiro EE, da Cruz IB, Suleiman L, Soares FA. Guarana (Paullinia cupana Kunth) effects on LDL oxidation in elderly people: an in vitro and in vivo study. Lipids Health Dis 2013; 12: 12, doi: 10.1186/1476-511X-12-12.
  » https://doi.org/10.1186/1476-511X-12-12

Publication Dates

• Publication in this collection
  2018

History

• Received
  16 Mar 2018
• Accepted
  15 May 2018